Announced Wed, 16 Sept, 2026 · 15:44 IST
Chairman's Letter outlines imaging products, SE Asia growth, promoter capital infusion
Order Pipeline DisclosedAnalyst Day Multiyear TargetsInvestor Communications View source PDFExplain this filing
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.2%1-day move
₹33.50
prior close
₹32.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.1+3.2+3.0+2.9+0.2-2.3+0.2+4.7+2.2+2.5————
Up moveDown movePending
AI summary
Chairman detailed FY26 progress: Radiology segment covers MRI, CT, X-ray products including AURIX, NEONA and CLARION. Won Rs 9.29 crore 65-unit Tamil Nadu government order. Entered Indonesia with TB screening programme and Philippines via Bulacan MRI and Catanduanes deployment. Plans 20 AI rehabilitation centres in Malaysia over two years. Promoter group infused around Rs 59.67 crore via warrants conversion and preferential allotment, raising promoter stake from 62.15 to 63.08 percent.
Likely market impact
Signals revenue traction, international expansion across Southeast Asia and promoter confidence through fresh capital infusion.